Characterization of Extended-Spectrum β-Lactamase Genes of Shigella flexneri Isolates With Fosfomycin Resistance From Patients in China
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: The emergence of fosfomycin resistance and extended-spectrum β-lactamase (ESBL) genes is a serious threat to public health and a new challenge in shigellosis treatment. The purpose of this study was to identify fosfomycin resistance and characterize β-lactamase genes in fos-carrying isolates of Shigella flexneri from patients in China. Methods: A total of 263 S. flexneri isolates were collected from 34 hospitals in the Anhui Province of China during September 2012-September 2015 and screened for fosA3, fosA, and fosC2 by PCR amplification and sequencing. The fos-carrying isolates were then screened for β-lactamase genes. The clonal relationships between fosA3-carrying isolates, the transmissibility of fosfomycin resistance, replicon types of plasmids carrying fosfomycin resistance genes and other associated resistance genes were investigated. Results: Twenty-five of the 263 isolates (9.5%) showed resistance to fosfomycin, and 18 (6.8%) were positive for fosA3. None of the isolates was positive for fosA or fosC2. Seventeen of the isolates carrying fosA3 (94%) were CTX-M producers (seven CTX-M-55, five CTX-M-14, and five CTX-M-123), while three (16.7%) were TEM producers (TEM-1).Sixteen (88.9%) fosA3-carrying isolates exhibited multi-drug resistance. The replicon types of the 13 fosA3-carrying plasmids were IncF (n=13), IncHI2 (n=3), IncIl-Ir (n=2), and IncN (n=1). Conclusions: Our results indicated that fosA3 could spread through plasmids in S. flexneri isolates, along with the blaCTX-M and blaTEM, which facilitate its quick dispersal. To the best of our knowledge, this is the first report of CTX-M-123-type ESBLs in S. flexneri isolates from patients in China.
Abstract
Background: The emergence of fosfomycin resistance and extended-spectrum β-lactamase (ESBL) genes is a serious threat to public health and a new challenge in shigellosis treatment. The purpose of this study was to identify fosfomycin resistance and characterize β-lactamase genes in fos-carrying isolates of Shigella flexneri from patients in China. Methods: A total of 263 S. flexneri isolates were collected from 34 hospitals in the Anhui Province of China during September 2012-September 2015 and screened for fosA3, fosA, and fosC2 by PCR amplification and sequencing. The fos-carrying isolates were then screened for β-lactamase genes. The clonal relationships between fosA3-carrying isolates, the transmissibility of fosfomycin resistance, replicon types of plasmids carrying fosfomycin resistance genes and other associated resistance genes were investigated. Results: Twenty-five of the 263 isolates (9.5%) showed resistance to fosfomycin, and 18 (6.8%) were positive for fosA3. None of the isolates was positive for fosA or fosC2. Seventeen of the isolates carrying fosA3 (94%) were CTX-M producers (seven CTX-M-55, five CTX-M-14, and five CTX-M-123), while three (16.7%) were TEM producers (TEM-1).Sixteen (88.9%) fosA3-carrying isolates exhibited multi-drug resistance. The replicon types of the 13 fosA3-carrying plasmids were IncF (n=13), IncHI2 (n=3), IncIl-Ir (n=2), and IncN (n=1). Conclusions: Our results indicated that fosA3 could spread through plasmids in S. flexneri isolates, along with the blaCTX-M and blaTEM, which facilitate its quick dispersal. To the best of our knowledge, this is the first report of CTX-M-123-type ESBLs in S. flexneri isolates from patients in China.
참고문헌 (22)
- Christopher PR, "Antibiotic therapy for Shigella dysentery", Cochrane Database Syst Rev, pp.CD006784~ (2010)
- Wang XY, "Trend and disease burden of bacillary dysentery in China (1991-2000)", Bull World Health Organ, 84, pp.561~568 (2006)
- Falagas ME, "Fosfomycin for the treatment of multidrug-resistant, including extended-spectrum β-lactamase producing, Enterobacteriaceae infections: a systematic review", Lancet Infect Dis, 10, pp.43~50 (2010)
- Falagas ME, "Fosfomycin: use beyond urinary tract and gastrointestinal infections", Clin Infect Dis, 46, pp.1069~1077 (2008)
- Samonis G, "Antimicrobial susceptibility of Gram-negative nonurinary bacteria to fosfomycin and other antimicrobials", Future Microbiol, 5, pp.961~970 (2010)
- Wachino J, "Prevalence of fosfomycin resistance among CTX-M-producing Escherichia coli clinical isolates in Japan and identification of novel plasmid-mediated fosfomycin-modifying enzymes", Antimicrob Agents Chemother, 54, pp.3061~3064 (2010)
- Lee SY, "Prevalence of acquired fosfomycin resistance among extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae clinical isolates in Korea and IS26-composite transposon surrounding fosA3", J Antimicrob Chemother, 67, pp.2843~2847 (2012)
- Ho PL, "Prevalence and molecular epidemiology of plasmid-mediated fosfomycin resistance genes among blood and urinary Escherichia coli isolates", J Med Microbiol, 62, pp.1707~1713 (2013)
- Sato N, "First detection of fosfomycin resistance gene fosA3 in CTX-M-producing Escherichia coli isolates from healthy individuals in Japan", Microb Drug Resist, 19, pp.477~482 (2013)
- Tseng SP, "Characterization of fosfomycin resistant extended-spectrum β-lactamase-producing Escherichia coli isolates from human and pig in Taiwan", PLoS One, 10, pp.e0135864~ (2015)
- Hou J, "Dissemination of the fosfomycin resistance gene fosA3 with CTX-M β-lactamase genes and rmtB carried on IncFII plasmids among Escherichia coli isolates from pets in China", Antimicrob Agents Chemother, 56, pp.2135~2138 (2012)
- Kim S, "Occurrence of extended-spectrum β-lactamases in members of the genus Shigella in the Republic of Korea", J Clin Microbiol, 42, pp.5264~5269 (2004)
- Carattoli A, "Identification of plasmids by PCR-based replicon typing", J Microbiol Methods, 63, pp.219~228 (2005)
- Hu GZ, "Phenotypic and molecular characterization of TEM-116 extended-spectrum β-lactamase produced by a Shigella flexneri clinical isolate from chickens", FEMS Microbiol Lett, 279, pp.162~166 (2008)
- Fortineau N, "SHV-type extended-spectrum β-lactamase in a Shigella flexneri clinical isolate", J Antimicrob Chemother, 47, pp.685~688 (2001)
- Paterson DL, "Extended-spectrum β-lactamases: a clinical update", Clin Microbiol Rev, 18, pp.657~686 (2005)
- Taneja N, "Cephalosporin-resistant Shigella flexneri over 9 years (2001-09) in India", J Antimicrob Chemother, 67, pp.1347~1353 (2012)
- Xiong Z, "Detection of CTX-M-14 extended-spectrum β-lactamase in Shigella sonnei isolates from China", J Infect, 55, pp.e125~e128 (2007)
- Xia S, "Prevalence and characterization of human Shigella infections in Henan Province, China, in 2006", J Clin Microbiol, 49, pp.232~242 (2011)
- Zhang W, "Wide dissemination of multidrug-resistant Shigella isolates in China", J Antimicrob Chemother, 66, pp.2527~2535 (2011)
- He D, "CTX-M-123, a novel hybrid of the CTX-M-1 and CTX-M-9 Group β-lactamases recovered from Escherichia coli isolates in China", Antimicrob Agents Chemother, 57, pp.4068~4071 (2013)
- Alrowais H, "Fosfomycin resistance in Escherichia coli, Pennsylvania, USA", Emerg Infect Dis, 21, pp.2045~2047 (2015)